CYP2D6 phenotypes and opioid metabolism: the path to personalised analgesia.


Por: Ballester P, Muriel J and Peiró AM

Publicada: 10 jun 2022 Ahead of Print: 1 jun 2022
Resumen:
INTRODUCTION: Opioids play a fundamental role in chronic pain, especially considering when 1 of 5 Europeans adults, even more in older females, suffer from it. However, half of them do not reach an adequate pain relief. Could pharmacogenomics help to choose the most appropriate analgesic drug? AREAS COVERED: The objective of the present narrative review was to assess the influence of cytochrome P450 2D6 (CYP2D6) phenotypes on pain relief, analgesic tolerability and potential opioid misuse. Until December 2021, a literature search was conducted through the MEDLINE, PubMed database, including papers from the last 10 years. CYP2D6 plays a major role in metabolism that directly impacts on opioid (tramadol, codeine or oxycodone) concentration with differences between sexes, with a female trend towards poorer pain control. In fact, CYP2D6 gene variants are the most actionable to be translated into clinical practice according to regulatory drug agencies and international guidelines. EXPERT OPINION: CYP2D6 genotype can influence opioids' pharmacokinetics, effectiveness, side effects, and average opioid dose. This knowledge needs to be incorporated in pain management. Environmental factors, psychological together with genetic factors, under a sex perspective, must be considered when you are selecting the most personalized pain therapy for your patients.

Filiaciones:
:
 Neuropharmacology on Pain (NED) group, Alicante Institute for Health and Biomedical Research (ISABIAL Foundation), Alicante, Spain

:
 Neuropharmacology on Pain (NED) group, Alicante Institute for Health and Biomedical Research (ISABIAL Foundation), Alicante, Spain

:
 Neuropharmacology on Pain (NED) group, Alicante Institute for Health and Biomedical Research (ISABIAL Foundation), Alicante, Spain

 Clinical Pharmacology Unit, Department of Health of Alicante - General Hospital, Alicante (Spain)
ISSN: 17425255
Editorial
Informa Healthcare, England, Reino Unido
Tipo de documento: Article
Volumen: 18 Número: 4
Páginas: 261-275
WOS Id: 000809512200001
ID de PubMed: 35649041

MÉTRICAS